Cargando…
Problems and challenges encountered by Chinese medical institutions in implementing the national centralized drug procurement
Objective: The problems and challenges encountered by Chinese medical institutions in implementing the national centralized drug procurement was investigated and analyzed in order to provide reference for the regulatory agencies to formulate policies. Methods: A questionnaire survey was conducted to...
Autores principales: | Zhang, Wen, Xu, Qingwen, Peng, Jing, Zhang, Xiaotong, Chen, Lu, Wu, Yilai, Yang, Kui, Luan, Jiajie, Liu, Xiaoyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10513935/ https://www.ncbi.nlm.nih.gov/pubmed/37745061 http://dx.doi.org/10.3389/fphar.2023.1233491 |
Ejemplares similares
-
Does China improve social welfare after implementing the national volume-based procurement?
por: Wang, Huan, et al.
Publicado: (2023) -
Impact of National Volume-Based Procurement on the Procurement Volumes and Spending for Antiviral Medications of Hepatitis B Virus
por: Yuan, Jing, et al.
Publicado: (2022) -
Antibiotic Use in China’s Public Healthcare Institutions During the COVID-19 Pandemic: An Analysis of Nationwide Procurement Data, 2018–2020
por: Yang, Ying, et al.
Publicado: (2022) -
Healthcare professionals’ knowledge, attitude and practice towards National Centralized Drug Procurement policy in central China: A cross-sectional study
por: Huang, Anqi, et al.
Publicado: (2022) -
The change of drug utilization in China’s public healthcare institutions under the “4 + 7” centralized drug procurement policy: Evidence from a natural experiment in China
por: Lu, Jiancheng, et al.
Publicado: (2022)